Board of Directors

Board of Directors

Nick Lewin
Nick Lewin
Chairman
Mr. Lewin has served on our board of directors since September 2015. He has been a Managing Partner at Crown Predator Holdings since 2000 and has been a private investor since 2000. Invested across multiple industries, and throughout the capital structure, with a particular focus on companies with innovative technologies and strong intellectual property, including activist situations that require working with management. As director of Halo Maritime Defense Systems, he is a held provider of maritime security products and solutions since 2007. Mr. Lewin holds a bachelor’s degree in Political Science from Johns Hopkins University.
jj bod
Juan José Chacón-Quirós
CEO & Founder
Mr. Chacón-Quirós is the Founder, Chief Executive Officer, and Board Director of Establishment Labs® (NASDAQ : ESTA). Mr. Chacón Quirós has been involved in several sectors of the aesthetics industry, serving for a decade as General Manager of an aesthetic medical device distribution business in Latin America and prior to this as Business Development Manager of a renowned plastic and reconstructive surgery clinic. He has authored and co-authored more than 50 patents that are helping advance technology in areas like implants and surfaces, RFID and biosensors, 3D technology, and surgical instruments development. Served as President of the Rugby Federation of Costa Rica and is currently on the board of South America Rugby and the board of directors of the Latin American and Caribbean Business Forum. Mr. Chacón-Quirós received a degree from the Academie de Poitiers (Economie) and attended the University of Massachusetts at Amherst. He holds the MIT Sloan Advanced Certificate for Executives (ACE) in Management, Innovation, and Technology.
Lisa Colleran
Lisa Colleran
Ms. Colleran has served on our board of directors since November 2015. She served as Global President of LifeCell Corporation from August 2008 to January 2012 after the company was acquired by Kinetic Concepts, Inc. In January 2012, Ms. Colleran was appointed Chief Executive Officer and Director of LifeCell Corporation, a position she held until April 2013. Ms. Colleran originally joined LifeCell in 2002 as the Vice President of Marketing and Business Development and later served as Senior Vice President of Commercial Operations. Prior to joining LifeCell, Ms. Colleran spent 20 years at Baxter Healthcare Corporation in various sales, marketing, business development and general management roles with international experience. She was appointed Vice President, Marketing for Baxter’s U.S. Renal business in 1997 and served in that role until 2001 when she was promoted to Vice President/General Manager of the company’s Renal Pharmaceuticals business. Ms. Colleran received her Bachelor of Science from Molloy College and an M.B.A. from Loyola University of Chicago.
Dennis Condon
Dennis Condon
A board member since December 2017 that brings 35 years of experience in the plastic surgery sector, including the breast implant market as President of Mentor Aesthetics from 1990 to 1998. Most recently, Mr. Condon was the CEO and President of Nuvesse Skin Therapies, a venture-backed cosmeceutical skincare company serving the U.S. medical device and retail skin care markets, until its sale to a Korean pharmaceuticals company in 2016. Before joining Nuvesse, he was CEO and President of Merz Aesthetics, Inc. and President and Chief Business Officer of BioForm Medical. BioForm was acquired by Merz Pharma in January 2010. He has also lead other aesthetic companies, acting as CEO of a cosmetic laser company and CEO of a national chain of cosmetic surgery centers. Currently serving on the boards of Suneva Medical Inc., which commercializes the longest-lasting dermal filler for facial fine lines and wrinkles. Mr. Condon has a BS in Biological Sciences from the University of California, Davis.
Ann Custin
Ann Custin
Ms. Custin has served on our board since July 2021. Ms. Custin brings extensive global experience in the healthcare sector. Her most recent executive role was with Siemens Healthineers, a leading global medical technology company, where she served as both Chief Financial Officer and Board Director of Siemens Medical Solutions, Inc.   Previously, Ms. Custin served as Chief Operating and Financial Officer of Scient’x and President & CEO of Draeger Medical Systems, USA. Ms. Custin is a non-executive director of both ASX listed Volpara Health Technologies, and ASX listed Mayne Pharma Group. Ms. Custin has a BA Accounting degree from Queens College, NY.
Ed Schutter
Ed Schutter
Ed Schutter has over thirty years of pharmaceutical industry experience and is currently CEO of Arbor Pharmaceuticals. Ed was previously President of Sciele (Shionogi) Pharmaceuticals prior to joining Arbor. Prior to Sciele, Ed served as VP of Global Business development at Solvay Pharmaceuticals based in Basel, Switzerland. He also held several senior management roles at the U.S. subsidiary of Solvay during his twenty years with the organization. He began his pharmaceutical career with Reid-Provident Labs, a small entrepreneurial pharmaceutical company based in Atlanta, GA. Ed is a registered pharmacist with a BS in Pharmaceutical Sciences from Mercer University, an MBA from Kennesaw State University and has completed graduate studies in International Business at Njienrode University, Amsterdam, Netherlands. He is currently a board member of Arbor, Vitruvias Therapeutics, Terrascend (TER.CN) and Establishment Labs (ESTA, NASDQ) and has been a previous board member of Knight Therapeutics (GUD.TO), Mercer University Board of Trustees, American Diabetes Association, American Heart Association as well as several other private pharma companies and nonprofit organizations.
Bryan Slotkin
Bryan Slotkin
Bryan J. Slotkin is a Partner in the Strategic Advisory Group at PJT Partners, based in Los Angeles. Bryan joined PJT Partners in June of 2018, following a partnership role at Discovery Land Company and a 23-year career as an investment banker. He spent the last 10 years of his investment banking career at Goldman Sachs where he was responsible for the West Coast Financial Sponsor franchise and previously responsible for the West Coast Real Estate, Gaming, and Leisure business. Bryan managed and executed transactions for many of the firm’s largest and most important private equity, family office, real estate, gaming, leisure, and sponsor owned portfolio company relationships. Before joining Goldman Sachs, Bryan was a director in the technology, media, and telecom group at Citigroup Global Markets and also served as a Mergers & Acquisitions specialist at Bank of America Securities LLC. He is also a member of the Rutgers Business School Board of Advisors and an Ambassador to the Board of Trustees of the US Ski and Snowboard Association. Mr. Bryan received a BS in Finance from Rutgers College and a JD/MBA from George Washington University.
Leslie Gillin
Leslie Gillin
A member of our board of directors since December 2021. She is currently the Chief Growth Officer of Pagaya, a financial technology company working to reshape the lending marketplace by using machine learning, big data analytics, and sophisticated AI-driven analysis technology. Leslie was most recently the Chief Marketing Officer for JP Morgan Chase as well as Chase’s President of CoBrand Cards. Before joining Chase, she was the Chief Marketing Officer of Citi’s Global Consumer Bank, accountable for driving business growth across 18 countries. Previously, Leslie served more than 25 years in senior marketing, product, and business development roles at Citi, Bank of America, and MBNA, including assignments in Canada and the U.K. Leslie earned a bachelor’s degree in International Relations and Spanish from the University of Delaware and attended the University of Salamanca. She was recognized as a Top 25 CMOs to Watch by Business Insider in 2020.